SAS Helps Executives at Aeris Therapeutics Breathe Easier

Overview

Patients suffering from advanced emphysema today have very few options for relieving their symptoms. One option is high-risk, open-chest surgery to remove damaged regions of the lung. Aeris Therapeutics, a start-up biopharmaceutical firm based in Woburn, Mass., has pioneered the Aeris BLVR System, a treatment regimen that would provide a non-surgical alternative for reducing the damaged portions of patients' lungs and helping them breathe more comfortably. In an effort to accelerate the clinical trial process for the Aeris BLVR System while substantially reducing costs, Aeris Therapeutics has selected SAS Enterprise BI Server to serve as a platform for improving operational efficiency and decision making, establishing consistency in data quality, and delivering more timely information in the approval process and beyond.